Yahoo Finance Amgen Is 'Very Encouraged' With Its Obesity Drug. But Can It Take On Novo, Lilly Duopoly?
Amgen stock neared its record high Friday after the company said it's "very encouraged" with midstage test results for its obesity treatment.
Amgen stock neared its record high Friday after the company said it's "very encouraged" with midstage test results for its obesity treatment.
Warren Buffett’s right-hand man knew a thing or two about investing.
Tax time is just around the corner. Make sure you don’t miss out on these commonly overlooked deductions.
"I found a dentist who would book me a chair for a full day and would come back every 30 to 60 min and give me more anesthesia. Usually, by about hour six, I would finally be numb."
Why the entrepreneur thinks “moats are lame”
US markets have had a rough week. The Dow has fallen by around 1,000 points over the last three days alone — and the negative momentum didn’t let up Thursday.
Ava Hatcher's parents knew something was 'different' seconds after her birth.
Experts warn that the cost of living could have lasting health impacts. find out more here.
Aussie fast food chain Guzman y Gomez has made a huge announcement on the future of the company which could spark a $200m expansion across the country.
People on low incomes end up paying more than those who have full access to mainstream financial services.
(Bloomberg) -- A renewed bout of volatility gripped US stocks in the final stretch of May, with dip buying pushing the market higher amid a rotation between technology and other industries.Most Read from BloombergWall Street Billionaires Are Rushing to Back Trump, Verdict Be DamnedModi Set for Landslide Election Win in India, Exit Polls ShowTrump Is Guilty on All Counts in Hush-Money Case. Now What?Here Are the Latest Verified Results From South Africa’s ElectionDonald Trump Becomes First Former
Verizon, T-Mobile and AT&T are known as the three major players in the telecommunications industry. You might have already decided on which one you prefer when it comes to your phone service --...
Most readers would already be aware that Qube Holdings' (ASX:QUB) stock increased significantly by 10% over the past...
(Bloomberg) -- The ethics council for Norway’s $1.6 trillion sovereign wealth fund is investigating which companies are selling weapons to Israel for use in its war against Hamas in Gaza, and may advise divesting a “very limited” number of arms manufacturers.Most Read from BloombergWall Street Billionaires Are Rushing to Back Trump, Verdict Be DamnedTrump Is Guilty on All Counts in Hush-Money Case. Now What?Donald Trump Becomes First Former US President Guilty of CrimesS&P 500 Spikes in Final 20
A new large-scale study found that the age at which girls start menstruating is getting younger—and cycles are taking longer to become regular.
BEIJING (Reuters) -China's manufacturing activity unexpectedly fell in May, keeping alive calls for fresh stimulus as a protracted property crisis in the world's second-largest economy continues to weigh on business, consumer and investor confidence. "I think the data particularly reflects soft domestic demand, the housing sector continued to worsen and retail sales were not strong," said Xu Tianchen, senior economist at the Economist Intelligence Unit.
One crew member was so affected she reportedly collapsed and had to be held up by a colleague.
NEW YORK (Reuters) -Oil prices fell on Friday and posted a weekly loss as investors awaited an OPEC+ meeting on Sunday that will determine the fate of the producer group's output cuts. Brent futures for July delivery were down 24 cents, or 0.3%, to $81.62 a barrel, while the more liquid August contract was down 77 cents, or 0.8%, at $81.11. U.S. West Texas Intermediate (WTI) crude futures fell 92 cents, or 1.2%, at $76.99.
People like Lauren will have hundreds or even thousands of dollars added to their bill.
Investing.com-- Morgan Stanley analysts hiked their price targets on Toyota and Honda , while citing the latter as their top pick among Japanese automakers on improved profitability prospects and sustained shareholder returns.
The Southampton Clinical Trials Unit has been chosen to run the project.